Please wait a minute...
European Journal of Gynaecological Oncology  2019, Vol. 40 Issue (2): 331-333    DOI: 10.12892/ejgo4375.2019
Case Report Previous articles | Next articles
Squamous cell carcinoma of one cervix invading the cavity in a uterus didelphys
Lu-lu Fu1, Lian-wen Zheng1, Chun-hui Gu2, *()
1 Department of Obstetrics and Gynecology, the Second Hospital of Jilin University, Changchun, China
2a Department of Obstetrics and Gynecology, Hulunbeier People's Hospital, Inner Mongolia, China
2b Department of Obstetrics and Gynecology, Chifeng Municipal Hospital, Inner Mongolia, China
Download:  PDF(312KB)  ( 210 ) Full text   ( 4 )
Export:  BibTeX | EndNote (RIS)      
Abstract  
Purpose: To report a case of a woman diagnosed with squamous cell carcinoma in one cervix invading the cavity ipsilaterally in a uterus didelphys and to discuss the diagnosis and treatment for such coexistences. Materials and Methods: A 47-year-old woman was admitted with the complaint of intermittent abdominal pain on the right associated with the anus sank bilge feeling. It was diagnosed with squamous cell carcinoma in the right cervix invading the cavity in a uterus didelphys preoperatively (FIGO classification IIA2). Radical hysterectomy with bilateral salpingo-oophorectomy and bilateral pelvic lymphadenectomy were performed. Results: Pathological examination showed non-cornification of squamous cell carcinomas on the right cervix, which extended to the entire wall of the lower uterus; widely vascular tumor emboli and nerve invasion were detected. The smaller uterine and both vaginal walls were not affected. Then paclitaxel and carboplatin chemotherapy and radiation were performed. No findings suggested recurrence during two years of follow-up. Conclusion: The treatment for cervical cancer can be challenging because of the anatomical anomaly. Successful treatment is primarily facilitated by detection of such coexistences, and then, with the optimization of the available resources to customize the best possible plan for individual patients.
Key words:  Müllerian duct anomalies      Uterus didelphys      Cervical cancer      Treatment     
Published:  10 April 2019     
*Corresponding Author(s):  CHUN-HUI GU     E-mail:  905962329@qq.com

Cite this article: 

Lu-lu Fu, Lian-wen Zheng, Chun-hui Gu. Squamous cell carcinoma of one cervix invading the cavity in a uterus didelphys. European Journal of Gynaecological Oncology, 2019, 40(2): 331-333.

URL: 

https://ejgo.imrpress.com/EN/10.12892/ejgo4375.2019     OR     https://ejgo.imrpress.com/EN/Y2019/V40/I2/331

[1] Eda Kucuktulu, Ahmet Fatih Yurekli. Simultaneous Integrated Intensity Modulated Radiotherapy Boost for Gynecological Cancer when Brachytherapy is not an Option[J]. European Journal of Gynaecological Oncology, 2020, 41(5): 720-725.
[2] Wook Youn Kim, Shin Hee Seo, Seung-Hyuk Shim, Jin Hee Park, Hyung Kyu Park, Kyeong A So, Tae Jin Kim, Sun Joo Lee. Correlation of immunohistochemistry and silver in situ hybridization for the assessment of c-MET in uterine cervical cancer patients treated with radical hysterectomy[J]. European Journal of Gynaecological Oncology, 2020, 41(5): 745-752.
[3] John P. Micha, Howard D. Epstein, Michael C. Roossin, Randy Bohart, Mark A. Rettenmaier, Bram H. Goldstein. Neoadjuvant chemotherapy, radical hysterectomy and chemoradiation for stage iva cervical carcinoma[J]. European Journal of Gynaecological Oncology, 2020, 41(5): 797-801.
[4] Juan Xu, Qingqing Tan, Ting Li. USP22 promotes the expression of GLUT1 and HK2 to facilitate growth and glycolysis in cervical cancer cells[J]. European Journal of Gynaecological Oncology, 2020, 41(5): 790-796.
[5] Yan qin Zhang, Di Wu, Meng qi Deng, Xiang yu Chang, Jin wei Miao, Yu mei Wu. Individual management of cervical cancer during pregnancy[J]. European Journal of Gynaecological Oncology, 2020, 41(5): 833-837.
[6] Yi-fan Luo, Li-xiang Ren, Ming-yan Jiang, Yang Chu. A systematic review and meta-analysis on the effects of metformin on survival outcomes and risk in women with cervical cancer[J]. European Journal of Gynaecological Oncology, 2020, 41(4): 504-507.
[7] Liman Yang, Jing Jin, Juhong Liu. Correlation of MMP2-C1306T (rs243865) and MMP7-181A/G (rs11568818) with cervical cancer: a meta-analysis[J]. European Journal of Gynaecological Oncology, 2020, 41(4): 508-512.
[8] Panteleimon Mnimatidis, Abraham Pouliakis, George Valasoulis, George Michail, Aris Spathis, Christine Cottaridi, Niki Margari, Maria Kyrgiou, Maria Nasioutziki, Alexandros Daponte, Konstantinos Dinas, Evangelos Paraskevaidis, Ioannis Panayiotides, Dimitrios-Dionysios Koutsouris. Multicentric assessment of cervical HPV infection co-factors in a large cohort of Greek women[J]. European Journal of Gynaecological Oncology, 2020, 41(4): 545-555.
[9] Fengmei Wang , Huachun Luo , Huihua Cheng, Huijuan Huang , Zhichao Fu. Is 3D printing-gided three-dimensional brachytherapy suitable for cervical cancer: from one single research institute?[J]. European Journal of Gynaecological Oncology, 2020, 41(4): 591-597.
[10] Hiroshi Yoshida, Megumi Yamamoto, Hiroyuki Shigeta. Successful treatment of uterine cervical carcinoma with extensive vaginal lesions using laparoscopic surgery: A case report[J]. European Journal of Gynaecological Oncology, 2020, 41(4): 629-633.
[11] Hikari Unno, Seiji Mabuchi, Isao Arai, Tomoko Wakasa, Seiichi Yamamasu. Development of lymphangiosarcoma after pelvic radiation therapy for uterine cervical cancer: A case report and literature review[J]. European Journal of Gynaecological Oncology, 2020, 41(3): 326-331.
[12] J. An, G. Ruan, X.Y. Xie, Y.Q. Shi, X.D. Mao, B.H. Dong, P.M. Sun. Endometrial stromal nodule: report of 8 cases and literature review[J]. European Journal of Gynaecological Oncology, 2020, 41(3): 332-338.
[13] L. Xu, H. Cai, N. Zhu, Bo Zheng. Interleukin-22 derived from cervical cancer-associated fibroblasts accelerates senescence of normal fibroblasts and promotes expression of tumorigenesis-related factors in HeLa cells[J]. European Journal of Gynaecological Oncology, 2020, 41(2): 192-199.
[14] Hong Yan, Chunhua Zhang, Tingting Liu, Jianzhong Liu. Mifepristone regulates the multidrug resistance via miR-758/MEPE of Hela cell lines[J]. European Journal of Gynaecological Oncology, 2020, 41(2): 214-220.
[15] K. Plagens–Rotman, M. Piskorz–Szymendera, B. PIĘTA. Lifestyle with particular emphasis on physical activity and genital carcinomas in women[J]. European Journal of Gynaecological Oncology, 2020, 41(2): 233-239.
No Suggested Reading articles found!